Beta Hemolytic Streptococcus

GRANDE RONDE HOSPITAL ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016 Beta Hemolytic Streptococcus Inpatient and Outpatient Is...
Author: Kristina Lynch
0 downloads 0 Views 81KB Size
GRANDE RONDE HOSPITAL

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Beta Hemolytic Streptococcus Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefuroxime

2nd Generation Cephalosporin

2

100

Cefotaxime

3rd Generation Cephalosporin

18

100

Ceftriaxone

3rd Generation Cephalosporin

18

100

Cefepime

4th Generation Cephalosporin

18

100

Ertapenem

Beta Lactam

18

94

Meropenem

Beta Lactam

19

100

Levofloxacin

Fluoroquinolone

19

100

Azithromycin

Macrolide

15

67

Erythromycin

Macrolide

15

67

Clindamycin

Other

15

67

Daptomycin

Other

17

100

Vancomycin

Other

19

100

Amoxicillin/Clav

Penicillin/Beta Lactam

17

100

Penicillin

Penicillins

17

100

Tetracycline

Tetracyclines

19

42

Page 1 of 14

NOTES

All isolates have been tested for inducible Clindamycin resistance

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Citrobacter spp Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefazolin

1st Generation Cephalosporin

34

0

Ceftazidime

3rd Generation Cephalosporin

35

94

Ceftriaxone

3rd Generation Cephalosporin

35

91

Cefepime

4th Generation Cephalosporin

35

100

Amikacin

Aminoglycoside

35

100

Gentamicin

Aminoglycoside

35

97

Ertapenem

Beta Lactam

35

97

Meropenem

Beta Lactam

35

100

Ciprofloxacin

Fluoroquinolone

34

91

Levofloxacin

Fluoroquinolone

34

91

Aztreonam

Monobactam

35

91

Nitrofurantoin

Other

31

84

Ampicillin/Sulbactam

Penicillin/Beta Lactam

35

63

Piperacillin/Tazobactam

Penicillin/Beta Lactam

35

100

Ampicillin

Penicillins

35

0

Trimeth/Sulfa

Sulfonamides

35

80

Tetracycline

Tetracyclines

34

79

Page 2 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Coag Neg Staph Group Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Gentamicin

Aminoglycoside

78

95

Ciprofloxacin

Fluoroquinolone

78

56

Levofloxacin

Fluoroquinolone

78

58

Erythromycin

Macrolide

41

41

Clindamycin

Other

41

76

Daptomycin

Other

77

100

Linezolid

Other

78

100

Nitrofurantoin

Other

37

100

Rifampin

Other

78

100

Vancomycin

Other

78

100

Ampicillin

Penicillins

78

0

Oxacillin

Penicillins

78

54

Penicillin

Penicillins

78

0

Trimeth/Sulfa

Sulfonamides

78

64

Tetracycline

Tetracyclines

78

82

Page 3 of 14

NOTES

All isolates have been tested for inducible Clindamycin resistance

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Enterobacter spp Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefazolin

1st Generation Cephalosporin

50

0

Ceftazidime

3rd Generation Cephalosporin

50

96

Ceftriaxone

3rd Generation Cephalosporin

50

92

Cefepime

4th Generation Cephalosporin

50

100

Amikacin

Aminoglycoside

50

100

Gentamicin

Aminoglycoside

50

98

Ertapenem

Beta Lactam

50

100

Meropenem

Beta Lactam

50

100

Ciprofloxacin

Fluoroquinolone

50

94

Levofloxacin

Fluoroquinolone

50

96

Aztreonam

Monobactam

50

94

Nitrofurantoin

Other

35

83

Ampicillin/Sulbactam

Penicillin/Beta Lactam

50

0

Piperacillin/Tazobactam

Penicillin/Beta Lactam

50

98

Ampicillin

Penicillins

50

0

Trimeth/Sulfa

Sulfonamides

50

90

Tetracycline

Tetracyclines

50

88

Page 4 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Enterococcus spp Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

NOTES

Gentamicin 500ug/mL

Aminoglycoside

104

88

Synergy Testing

Streptomycin 1000ug/mL

Aminoglycoside

104

85

Synergy Testing

Ciprofloxacin

Fluoroquinolone

86

65

Levofloxacin

Fluoroquinolone

87

72

Erythromycin

Macrolide

18

39

Daptomycin

Other

103

100

Linezolid

Other

105

97

Nitrofurantoin

Other

86

93

Rifampin

Other

104

70

Vancomycin

Other

105

97

Ampicillin

Penicillins

104

94

Penicillin

Penicillins

105

92

Page 5 of 14

2 VRE

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Escherichia coli Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefazolin

1st Generation Cephalosporin

715

93

Ceftazidime

3rd Generation Cephalosporin

715

99

Ceftriaxone

3rd Generation Cephalosporin

715

95

Cefepime

4th Generation Cephalosporin

715

99

Amikacin

Aminoglycoside

715

100

Gentamicin

Aminoglycoside

715

95

Ertapenem

Beta Lactam

715

100

Meropenem

Beta Lactam

715

100

Ciprofloxacin

Fluoroquinolone

715

88

Levofloxacin

Fluoroquinolone

715

89

Aztreonam

Monobactam

715

97

Nitrofurantoin

Other

683

99

Ampicillin/Sulbactam

Penicillin/Beta Lactam

715

76

Piperacillin/Tazobactam

Penicillin/Beta Lactam

715

100

Ampicillin

Penicillins

715

66

Trimeth/Sulfa

Sulfonamides

715

83

Tetracycline

Tetracyclines

715

82

Page 6 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Haemophilus influenza Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefuroxime

2nd Generation Cephalosporin

23

100

Ceftriaxone

3rd Generation Cephalosporin

23

100

Cefepime

4th Generation Cephalosporin

23

100

Levofloxacin

Fluoroquinolone

18

100

Clarithromycin

Macrolide

23

70

Amoxicillin/Clav

Penicillin/Beta Lactam

23

96

Ampicillin/Sulbactam

Penicillin/Beta Lactam

23

96

Ampicillin

Penicillins

23

74

Trimeth/Sulfa

Sulfonamides

23

48

Tetracycline

Tetracyclines

23

100

Page 7 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Klebsiella spp Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefazolin

1st Generation Cephalosporin

149

84

Ceftazidime

3rd Generation Cephalosporin

149

98

Ceftriaxone

3rd Generation Cephalosporin

149

98

Cefepime

4th Generation Cephalosporin

149

99

Amikacin

Aminoglycoside

149

99

Gentamicin

Aminoglycoside

149

98

Ertapenem

Beta Lactam

149

99

Meropenem

Beta Lactam

149

99

Ciprofloxacin

Fluoroquinolone

149

97

Levofloxacin

Fluoroquinolone

149

97

Aztreonam

Monobactam

149

99

Nitrofurantoin

Other

120

93

Ampicillin/Sulbactam

Penicillin/Beta Lactam

149

91

Piperacillin/Tazobactam

Penicillin/Beta Lactam

149

100

Ampicillin

Penicillins

149

0

Trimeth/Sulfa

Sulfonamides

149

91

Tetracycline

Tetracyclines

149

94

Page 8 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Proteus/Morganella/Providencia spp Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefazolin

1st Generation Cephalosporin

58

40

Ceftazidime

3rd Generation Cephalosporin

58

100

Ceftriaxone

3rd Generation Cephalosporin

58

98

Cefepime

4th Generation Cephalosporin

58

100

Amikacin

Aminoglycoside

58

100

Gentamicin

Aminoglycoside

58

97

Meropenem

Beta Lactam

58

91

Ciprofloxacin

Fluoroquinolone

58

76

Levofloxacin

Fluoroquinolone

58

81

Aztreonam

Monobactam

58

100

Nitrofurantoin

Other

47

0

Ampicillin/Sulbactam

Penicillin/Beta Lactam

58

81

Piperacillin/Tazobactam

Penicillin/Beta Lactam

58

100

Ampicillin

Penicillins

58

45

Trimeth/Sulfa

Sulfonamides

58

84

Tetracycline

Tetracyclines

58

0

Page 9 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Pseudomonas aeruginosa Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Ceftazidime

3rd Generation Cephalosporin

47

96

Cefepime

4th Generation Cephalosporin

47

98

Gentamicin

Aminoglycoside

47

100

Meropenem

Beta Lactam

47

96

Ciprofloxacin

Fluoroquinolone

47

85

Levofloxacin

Fluoroquinolone

47

87

Aztreonam

Monobactam

47

89

Piperacillin/Tazobactam

Penicillin/Beta Lactam

47

98

Page 10 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Staph aureus (MRSA) Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Gentamicin

Aminoglycoside

148

98

Ciprofloxacin

Fluoroquinolone

148

11

Levofloxacin

Fluoroquinolone

148

14

Erythromycin

Macrolide

136

5

Clindamycin

Other

136

84

Daptomycin

Other

147

100

Linezolid

Other

148

100

Nitrofurantoin

Other

12

100

Rifampin

Other

148

100

Vancomycin

Other

148

100

Ampicillin

Penicillins

148

0

Oxacillin

Penicillins

148

0

Penicillin

Penicillins

148

0

Trimeth/Sulfa

Sulfonamides

148

99

Tetracycline

Tetracyclines

148

95

Page 11 of 14

NOTES

All isolates have been tested for inducible Clindamycin resistance

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Staph aureus (not MRSA) Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Gentamicin

Aminoglycoside

183

100

Ciprofloxacin

Fluoroquinolone

183

85

Levofloxacin

Fluoroquinolone

183

87

Erythromycin

Macrolide

161

73

Clindamycin

Other

161

90

Daptomycin

Other

183

100

Nitrofurantoin

Other

22

100

Rifampin

Other

183

99

Vancomycin

Other

183

100

Ampicillin

Penicillins

182

0

Oxacillin

Penicillins

183

100

Penicillin

Penicillins

183

0

Trimeth/Sulfa

Sulfonamides

183

99

Tetracycline

Tetracyclines

183

95

Page 12 of 14

NOTES

All isolates have been tested for inducible Clindamycin resistance

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

Streptococcus pneumoniae Inpatient and Outpatient Isolates have been combined

ANTIBIOTIC

CLASS

Number of Isolates

% SUSCEPTIBLE

Cefuroxime

2nd Generation Cephalosporin

21

86

Cefotaxime (meningitis)

3rd Generation Cephalosporin

3

67

Cefotaxime (non-meningitis)

3rd Generation Cephalosporin

3

100

Ceftriaxone (meningitis)

3rd Generation Cephalosporin

4

75

Ceftriaxone (non-meningitis)

3rd Generation Cephalosporin

4

100

Levofloxacin

Fluoroquinolone

21

100

Azithromycin

Macrolide

20

80

Erythromycin

Macrolide

20

80

Vancomycin

Other

21

100

Amoxicillin/Clav

Penicillin/Beta Lactam

21

100

Penicillin (meningitis)

Penicillins

4

0

Penicillin (non-meningitis)

Penicillins

4

100

Trimeth/Sulfa

Sulfonamides

21

90

Tetracycline

Tetracyclines

21

90

Page 13 of 14

NOTES

Printed: 01/18/2017

ANTIBIOTIC SUSCEPTIBILITY OF COMMON ORGANISMS January - December 2016

CLSI STAPH VS BETA LACTAM SUSCEPTIBILITY IF PCN AND OXACILLIN SUSCEPTIBLE

IF PCN RESISTANT AND OXACILLIN SUSCEPTIBLE

IF PCN AND OXACILLIN RESISTANT

1st - CEFAZOLIN

susceptible

susceptible

resistant

1st - CEPHALEXIN

susceptible

susceptible

resistant

2nd - CEFPROZIL

susceptible

susceptible

resistant

2nd - CEFUROXIME

susceptible

susceptible

resistant

3rd - CEFDINIR

susceptible

susceptible

resistant

3rd - CEFOTAXIME

susceptible

susceptible

resistant

3rd - CEFTAZIDIME

susceptible

susceptible

resistant

3rd - CEFTRIAXONE

susceptible

susceptible

resistant

4th - CEFEPIME

susceptible

susceptible

resistant

ERTAPENEM

susceptible

susceptible

resistant

MEROPENEM

susceptible

susceptible

resistant

CEFOTETAN

susceptible

susceptible

resistant

CEFOXITIN

susceptible

susceptible

resistant

AMPICILLIN/ SULBACTAM

susceptible

susceptible

resistant

PIPERACILLIN/ TAZOBACTAM

susceptible

susceptible

resistant

AMOXICILLIN

susceptible

resistant

resistant

AMPICILLIN

susceptible

resistant

resistant

PEN G

susceptible

resistant

resistant

DICLOXACILLIN

susceptible

susceptible

resistant

NAFCILLIN

susceptible

susceptible

resistant

OXACILLIN

susceptible

susceptible

resistant

ANTIBIOTIC CLASS BETA LACTAMS (cephalosporins)

CARBEPENEMS

CEPHEMS

PENICILLINS (beta lactamase inhibitor combo)

PENICILLINS (penicillinase labile)

PENICILLINS (penicillinase stable)

Page 14 of 14

ANTIBIOTIC

Printed: 01/18/2017